MedPath

Impact of COVID-19 on Mental Health of Patients With Skin Picking

Not Applicable
Completed
Conditions
Skin Picking
Interventions
Other: Quality of life promotion
Behavioral: Internet-based Cognitive Behavioral Therapy
Registration Number
NCT04522492
Lead Sponsor
Hospital de Clinicas de Porto Alegre
Brief Summary

Skin Picking Disorder (SPD) affects up to 10% of the general population, causing significant socioeconomic damage in 75% of affected individuals. It is characterized by the repeated habit of touching the skin itself, causing or aggravating wounds, with difficulty in controlling the habit. It is associated with anxiety disorders in about 20% of cases and with depressive disorder in about 50%. Patients with SPD have difficulties in regulating emotions, being more vulnerable to having their mental symptoms aggravated in face of stressful situations, such as the current coronavirus-19 pandemia. Among the treatments available to SPD, cognitive behavioral therapy is the only intervention superior to placebo, and there is still no medication approved by the FDA indicated specifically to SPD. The effectiveness of cognitive behavioral therapy was assessed in a randomized clinical trial with Brazilian patients with SPD, but its long-term benefit has not yet been evaluated. Additionally, telemedicine interventions can be effective and used during pandemia, but the effectiveness of internet delivered cognitive behavioral therapy for SPD is not clear yet.

Detailed Description

This study is a randomized clinical trial, in which patients diagnosed with skin picking disorder (SPD) will be evaluated and, if symptomatic for the disease, will be randomized to one of the arms: intervention arm with 2 booster sessions of cognitive behavioral therapy in online format; active control arm, in which individuals will watch videos with quality of life orientation. Patients included in this study are coming from a brazilian clinical trial conducted between the years of 2014 and 2018, in wich patients with SPD were treated with a cognitive behavioral treatment protocol in individual or group formats, resulting in improvement of SPD symptoms and comorbid anxiety and depression. Before the intervention, individuals will be evaluated by a psychiatrist, to assess SPD and comorbid symptoms severity, thru the application of some instruments to assess SPD, anxiety, depression and emotional regulation. Also, the CRISIS questionnaire, about the impact of COVID-19 in mental health, will be applied. After the interventions, the instruments will be applied again, by the same evaluator, wich is blinded to the type of intervention that the patient received.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
18
Inclusion Criteria
  • Skin picking as a primary diagnosis
  • Treatment with cognitive behavioral therapy in the past, received in previous clinical randomized trial conducted by our research group between 2014 and 2018
Exclusion Criteria
  • Acute psychotic disorder, bipolar affective disorder in an acute episode, substance use disorder (except tobacco), severe depressive episode or suicidal ideation, dementia

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Quality of life promotionQuality of life promotionThe therapist will send to the patient 2 videos with strategies to improve quality of life during the pandemia (1 video about social support and one video about sleep hygiene). After 1 week, the therapist will send to the patient another 2 videos with strategies do improve quality of life (dietary guidance and guidance on physical activity)
internet CBTInternet-based Cognitive Behavioral TherapyInternet delivered cognitive behavioral therapy, thru 2 booster sessions. Each session will last 50 minutes. Fist session will involve: psychoeducation about the symptoms, evaluation of the skin picking habit, reinforcement of the habit reversal strategies. After 1 week, the second session will be applied, consisting of: strategies to cope with anxiety (breathing and muscle relaxation techniques) and to cope with depressive status (cognitive restructuring techniques).
Primary Outcome Measures
NameTimeMethod
Change in Global Clinical Impression Scale2 weeks

The skin picking improvement after intervention will be assessed by the change in the Global Clinical Impression Scale, applied by blinded evaluators.

Secondary Outcome Measures
NameTimeMethod
Change in Beck Anxiety Inventory2 weeks

Anxiety severity improvement after the intervention, assessed thru the Beck Anxiety Inventory

Change in Beck Depression Inventory2 weeks

Depression severity improvement after the intervention, assessed thru the Beck Depression Inventory

Change of Skin Picking Impact Scale2 weeks

Impact of Skin Picking in the life of the patient, assessed thru the Skin Picking Impact Scale

Change of emotional regulation2 weeks

Assess the correlation of emotional regulation, thru the DERS-36 (difficulties in emotional regulation scale), with the different skin picking subtypes (focused or automatic), thru the Milwaukee scale of dermatillomania subtypes.

Change in Hamilton Anxiety Scale2 weeks

Evaluate change in anxiety symptoms thru the Hamilton anxiety scale applied by blinded evaluators

Trial Locations

Locations (1)

Hospital de Clínicas de Porto Alegre

🇧🇷

Porto Alegre, Rio Grande Do Sul, Brazil

© Copyright 2025. All Rights Reserved by MedPath